Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabozantinib and Temozolomide in Leiomyosarcoma and Soft Tissue Sarcomas
NCT04200443Phase 2Active, not recruiting
- Sponsor
- City of Hope
- Start
- Jan 2020
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabozantinib in leiomyosarcoma (LMS), soft tissue sarcoma (STS), sponsored by City of Hope. Started Jan 2020; status: active, not recruiting.
02
Drugs
cabozantinib
03
Conditions
leiomyosarcoma (LMS)soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT04200443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04200443.